Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 13-Jul-2022 titled Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize���s Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal